Retatrutide 30mg – Research Peptide

Retatrutide 30mg is supplied as a high-purity lyophilized synthetic peptide formulated for laboratory research involving incretin receptor signaling and advanced metabolic pathway investigation. In controlled experimental environments, this compound is studied for its interaction with GLP-1, GIP, and glucagon receptor systems.

Retatrutide 30mg research peptide is supplied as a high-purity lyophilized synthetic compound for laboratory research applications.

We’ve published a detailed research comparison examining Retatrutide vs Tirzepatide in laboratory settings, including receptor targeting differences and signaling pathway considerations.

Read the full comparison here.

Research Applications

Retatrutide is evaluated in research models for:

• Triple receptor pathway engagement

• cAMP signaling modulation

• Intracellular metabolic cascade analysis

• Receptor interaction mapping

Its multi-receptor activation profile distinguishes it from dual-agonist compounds studied in related incretin research environments.

Tirzepatide

Product Specifications

• Compound: Retatrutide

• Strength: 30mg per via

l• Form: Lyophilized powder

• Purity: Research-grade (see COA)

• Storage: Refrigerated conditions recommended

• Intended Use: Laboratory Research Use Only

Certificate of Analysis

Each vial includes a QR code linking to the current Certificate of Analysis for batch

transparency and purity verification.

Current Active Batch: # ERL-2501-B007-T

View Current COA

Research Use Notice

This compound is supplied strictly for laboratory research use only. Not for human or animal consumption

Related Metabolic Research Peptides

Researchers studying Retatrutide may also examine:

• Tirzepatide 30mg– Research Peptide

 • AOD-9604– Research Peptide

 • MOTS-C– Research Peptide